Über das Unternehmen

We are the first HIPAA compliant platform that focuses on optimizing cancer treatment plans for patients in China locally. By connecting Chinese cancer patients to U.S. and Chinese oncologist and leveraging the existing medical facilities in China, we bring U.S. quality of care to Chinese cancer patients at less than 1/3 of the cost compared to medical travels to the U.S. Our pricing point is affordable by the top 40% of the income class in China.

CN
Unbekannt
Nicht verifiziertes Unternehmen